comparemela.com

Latest Breaking News On - Akorn operating - Page 1 : comparemela.com

Dry Eye Syndrome Drugs Market to grow by USD 2,159 21 million from 2022 to 2027; The growing geriatric population drives the market

/PRNewswire/ The dry eye syndrome drugs market is set to grow by USD 2,159.21 million from 2022 to 2027 progressing at a CAGR of 6.53% during the forecast.

United kingdomUnited statesJesse maidaNovaliq gmbNational institutes of healthOasis medical incGlaxosmithkline plcAkorn operating coCompany offeringAbbvie incAbbott laboratoriesF hoffmann la roche ltdViatris incPharmaceuticals ltdSanten pharmaceutical coPharma inc

Global Ophthalmic Surgical Devices Market to Grow at a Significant CAGR of 5 09% by 2028, Estimates DelveInsight | Bausch & Lomb, Topcon Corp , Johnson & Johnson, Carl Zeiss, Alcon, Lumenis, Hoya Corp , Ellex Medical, Ziemer Ophthalmic, Glaukos, Oertli Instrumente, NIDEK, IRIDEX Corp , HumanOptics |

The Global Ophthalmic Surgical Devices Market was valued at USD 8.91 billion in 2021 and growing at a CAGR of 5.09% during the forecast period (2023 to

United statesShruti thakurLeica microsystemsAdenovir pharmaThea pharmaTeva pharmaCarl zeiss meditecIntermedic arfranSonomed escalonSun pharmaTopcon corporationSurgical holdingsMarket researchEllex medical laser ltdSight sciences incSight sciences

Drugmaker Akorn goes bankrupt, recalls medicines for people, pets

The company terminated all employees at its US sites and discontinued its Quality program, leading to a voluntary recall of various products.

New yorkUnited statesNew jerseyDrug administrationWashington postAkorn operating companyAkorn operating coJeffrey greenberg universal images groupUniversal images groupGetty imagesOperating companyAkorn trusteeAkorn operating

Supplements Market size in US to grow by USD 17,708 13 million from 2022 to 2027; the increasing number of sales outlets to fuel market growth

/PRNewswire/ Technavio has been monitoring the supplements market in US, and it is expected to grow by USD 17,708.13 million from 2022 to 2027. As per the.

United kingdomUnited statesHitech pharmaPrnewswire technavioJesse maidaPfizer incCyanotech corpReckitt benckiser groupNutrition incLonza group ltdAmway corpAkorn operating coTechnavio researchOnline storesProduct serviceHealth inc

Drugmaker Akorn goes bankrupt, recalls medicines for people, pets

The company terminated all employees at its US sites and discontinued its Quality program, leading to a voluntary recall of various products.

New yorkUnited statesNew jerseyJeffrey greenberg universal images groupAkorn operating companyWashington postAkorn operating coDrug administrationUniversal images groupGetty imagesOperating companyAkorn trusteeAkorn operating

vimarsana © 2020. All Rights Reserved.